ライフサイエンスコーパス: carryover

1 derived from a PNT blastocyst with 4% mtDNA carryover.

2 ceptable reproducibility (<30%), and lack of carryover.

3 ing the extraction efficiency and desorption carryover.

4 arcoal-containing agar to reduce clofazimine carryover.

5 n lung against a background of oropharyngeal carryover.

6 rapid extraction of multiple samples without carryover.

7 ification of the wash procedure to eliminate carryover.

8 automated, high-throughput analyses without carryover.

9 ciency, with no evidence of sample-to-sample carryover.

10 ession of NRF-1 did not result from maternal carryover.

11 ct (C-->D), there was very little detectable carryover.

12 well as elimination of any potential sample carryover.

13 nse and reduce band broadening and/or solute carryovers.

14 A significant after-effect (carryover) also occurred when a subject prism-adapted re

15 but also offers a means for decontaminating carryover amplicons.

16 , requiring less than 5 s per sample without carryover and 1 s per sample, accepting minor cross cont

17 an enzymatic digestion step to eliminate PCR carryover and an exogenous internal positive control tha

18 raction chromatography to mitigate detergent carryover and improve liquid chromatography-mass spectro

19 Adding acetonitrile to sample eliminated carryover and improved LOD by 1.4- to 60-fold.

20 substantial loss in recovery, no observable carryover and no need for 'reactivation' of the PC surfa

21 It also eliminates sample-to-sample carryover and the requirement of instrument cleaning bet

22 a. 180 h(-1) (on the Mini 12) with no sample carryover and with inline derivatization in the case of

23 njection system did not show any significant carryover, and after thousands of injections, the system

24 , together with the probe's reproducibility, carryover, and recovery.

25 subfemtomole detection sensitivity, minimal carryover, and robust and stable electrospray throughout

26 op to drive cyclic mixing of the diluent and carryover, and two bus valves to control fluidic access

27 onsistent performance over many days without carryover, as long as washing buffers specific to each m

28 ace (OPSI) system as a simple noncontact, no-carryover, automated system for flow injection analysis

29 such as symmetrical peak shapes, low sample carryover (below 1%), and total injection cycle times of

30 .81, 95% CI 0.67-0.98; p=0.03), although the carryover benefit was smaller after 8 years.

31 No detectable carryover between runs was noted for the sputtered fiber

32 ny common fluid path, presents a low risk of carryover between successive analyses.

33 The method showed good sensitivity, without carryover between the samples.

34 ite blood cell yield, 0.0059% red blood cell carryover) by processing whole blood at 3 mL/min, or app

35 body transfer possesses minimal donor mtDNA carryover compared to the F1 generation from other proce

36 ster and more rugged extraction with reduced carryover compared with results obtained under laminar-f

37 The closed-tube system reduces the risk of carryover contamination and supports high throughput.

38 False-positive results due to carryover contamination are prevented by the incorporati

39 encing runs (>30) with negligible amounts of carryover contamination or degradation in the sequencing

40 ing results, virtual elimination of amplicon carryover contamination, and equivalent costs compared t

41 suggested as a possible means to prevent PCR carryover contamination.

42 assay simplified the workflow and minimized carryover contamination.

43 on per ml, we were unable to demonstrate any carryover cross-contamination of negative samples.

44 included in a fast event-related, continuous carryover design.

45 We tested carryover during array printing with dye solution, label

46 troduced into human oocytes by mitochondrial carryover during nuclear transfer often vanish, they can

47 ally higher rRNA:mRNA ratios and higher rRNA carryover during RNA-seq analysis.

48 independent of the degree of the beneficial carryover effect after aromatase inhibitor therapy or th

49 s), nor was there a significant differential carryover effect from one period to the next.

50 nt effect on carnivore efficiency suggests a carryover effect of algal quality across 3 trophic level

51 No significant carryover effect was observed.

52 Neither a period nor differential carryover effect was observed.

53 were analyzed for a direct and a first-order carryover effect, there was a significant difference in

54 L) could be directly analyzed without sample carryover effect, thereby enabling high-throughput analy

55 tation during the previous summer had a weak carryover effect, with migrants switching slightly more

56 Without carryover effects (i.e., initial transfer from the 32- a

57 rossover design showed significant (p<0.005) carryover effects (ie, lasting longer than 1 week).

58 ents, and food-chain length and suggest that carryover effects across multiple trophic levels are imp

59 low as approximately 0.1% are identified and carryover effects are minimized in high-throughput on-li

60 olled trial that was balanced for period and carryover effects in 28 healthy, young-adult men.

61 Direct and carryover effects of treatment were compared in the two

62 trained with small sets (e.g., 8 items) have carryover effects that hamper transfer when the training

63 subject treatment comparisons were made, and carryover effects were evaluated.

64 No carryover effects were observed.

65 when the drug was actually present (i.e., no carryover effects), increased cell firing also parallele

66 mechanistic understanding and prediction of carryover effects, and emphasize that local conservation

67 apid near-Nernstian response with negligible carryover effects, and good resiliency against various m

68 e reused after regeneration of beads with no carryover effects.

69 the 12 animals given CX516 did not exhibit "carryover" effects of the drug to the intervening (vehic

70 ion, can be monitored simultaneously without carryover for several hours.

71 varying the valve placement in the circuit, carryover fractions from 0.04 to 0.2 were obtained.

72 oval of liquids from the reaction vessel for carryover-free operations.

73 containing fluorescent Ags, suggestive of Ag carryover from HBEC to EMP.

74 MS/MS) analysis indicated significant sample carryover from previous injections of authentic standard

75 te that, by increasing the pressure, protein carryover from run to run is reduced and in some cases e

76 nsitivity due to exposure to extra surfaces, carryover from run to run, and increased dead volume.

77 0.5 and 0.75 ng/mL, respectively; persistent carryover from the autosampler limited the LOQ achievabl

78 This suggests Hg carryover from winter to summer periods and that variati

79 The potential of Hg carryover from wintering sites indicates that Hg concent

80 Specifically, protein carryover ("ghosting") and recovery were examined.

81 ng between samples with no detectible sample carryover has been performed.

82 , the consequences of small amounts of mtDNA carryover have not been studied sufficiently.

83 n, multiplication, and division, including a carryover into multiple cells.

84 y eliminates the mRNA complement, preventing carryover into the next cycle.

85 The response base width for 1% carryover is <95 s, permitting a throughput of 38 sample

86 context-dependent and that the magnitude of carryover is dependent on the VR in which adaptation occ

87 Carryover is inconsequential in the ESI emitter and betw

88 on in internal volumes and associated sample carryover issues will be among the first simple improvem

89 low chromatographic reproducibility and high carryover), nonspecific binding of analyte to containers

90 ximately 10(9) cells per round) with minimal carryover of cheaters after each round.

91 orm rapid sample preparation with low (0.6%) carryover of contaminants from the original sample.

92 itive results as a result of either amplicon carryover of cross-contamination between patient samples

93 Carryover of Hg among seasons and slow changes in [Hg] o

94 of winter habitat or diet suggesting minimal carryover of isotopic signatures.

95 We speculate that carryover of passenger donor lymphocytes within the tran

96 hat no anomalous amplification occurs due to carryover of primers or incomplete digestion from the en

97 priate discrimination in both tasks, with no carryover of the approach-relevant discrimination to the

98 SCUSSION: DMF appeared generally safe and no carryover PML among investigated cases was observed.

99 Carryover potential was subsequently assessed by perform

100 Analyte carryover problem encountered was solved by adding 20% a

101 sing recovery and matrix effect, autosampler carryover, run size, stability, and data reproducibility

102 t (V-->D), there was a significantly smaller carryover than from both D-->V and D-->C.

103 then prisms were removed, there was a large carryover to initial reaches in Video or Cursor (D-->V a

104 The importance of reducing carryover to the lowest possible levels is highlighted b

105 No system carryover was detected even when the same device was use

106 of S1P and DHS1P without significant sample carryover was developed.

107 After optimization, mtDNA carryover was reduced to <2% in the majority (79%) of PN